×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Fabrice Lécuru

Au programme de cette soirée

18:00 Introduction
Fabrice Lécuru
 
18:05 Cancer de l'ovaire et oncoGériatrie : réflexions autour de cas cliniques
Florence Rollot, Médecin interniste - Gériatre
 
18:30 La prise en charge nutritionnelle dans le cancer de l'ovaire
Timothée Marchal, Médecin de soins de support, spécialisé en nutrition
 
18:55 Place des soins palliatifs précoces pour les patientes symptomatiques de la carcinose péritonéale
Carole Bouleuc, Médecin de soins palliatifs
 
19:20 Débat/Discussion et réponses aux questions
 

 

Shooting date : 2022-11-15
Last update : 2022-11-16
1 comment
Join the Discussion
  • NADIA A. Merci à tous les quatre

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, September 10th 2024 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, September 10th 2024 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, September 10th 2024 from 09am to 10:30am (GMT+2)
    New York : Tuesday, September 10th 2024 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, September 10th 2024 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, September 10th 2024 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, September 10th 2024 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, September 10th 2024 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, September 10th 2024 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 10th 2024 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, September 10th 2024 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, September 11th 2024 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, September 11th 2024 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, September 11th 2024 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, September 11th 2024 from 05am to 06:30am (GMT+2)

    iPARP et cancer de l’ovaire : quand et pour qui ?

    Share
    Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, April 12th 2022 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, April 12th 2022 from 09am to 10:30am (GMT+2)
    New York : Tuesday, April 12th 2022 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, April 12th 2022 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, April 12th 2022 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, April 12th 2022 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, April 12th 2022 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 12th 2022 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, April 12th 2022 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, April 13th 2022 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, April 13th 2022 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, April 13th 2022 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, April 13th 2022 from 05am to 06:30am (GMT+2)

    Cancers séreux de bas grade

    Share
    Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Honolulu : Wednesday, May 18th 2022 from 06:30am to 08am (GMT+2)
    San Francisco : Wednesday, May 18th 2022 from 09:30am to 11am (GMT+2)
    New York : Wednesday, May 18th 2022 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Wednesday, May 18th 2022 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Istanbul : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
    Bangkok : Wednesday, May 18th 2022 from 11:30pm to 01am (GMT+2)
    Shanghai : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
    Tokyo : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
    Sydney : Thursday, May 19th 2022 from 03:30am to 05am (GMT+2)
    Wellington : Thursday, May 19th 2022 from 05:30am to 07am (GMT+2)

    Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire

    Share
    Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
    New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

    Last improvements in advanced ovarian cancer treatment

    Trials that have or will impact practices in the management of patients with advanced ovarian cancer

    Share
    Scroll Up